InvestorsObserver
×
News Home

Should You Accumulate Genprex Inc (GNPX) in Biotechnology Industry?

Tuesday, April 20, 2021 02:38 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Genprex Inc (GNPX) in Biotechnology Industry?

Genprex Inc (GNPX) is near the top in its industry group according to InvestorsObserver. GNPX gets an overall rating of 53. That means it scores higher than 53 percent of stocks. Genprex Inc gets a 84 rank in the Biotechnology industry. Biotechnology is number 102 out of 148 industries.

Overall Score - 53
GNPX has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on GNPX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 53 means the stock is more attractive than 53 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Genprex Inc Stock Today?

Genprex Inc (GNPX) stock is trading at $3.38 as of 2:38 PM on Tuesday, Apr 20, a drop of -$0.44, or -11.52% from the previous closing price of $3.82. The stock has traded between $3.22 and $3.88 so far today. Volume today is high. So far 1,469,388 shares have traded compared to average volume of 965,513 shares.

Click Here to get the full Stock Score Report on Genprex Inc (GNPX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App